Literature DB >> 20956126

Update on severe asthma: what we know and what we need.

M Gaga1, E Zervas, P Chanez.   

Abstract

Mesh：

Year:  2009        PMID： 20956126     DOI： 10.1183/09059180.00001009

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN： 0905-9180


× No keyword cloud information.
  6 in total

Review 1.  Golimumab and malignancies: true or false association?

Authors:  Ines Zidi; Aicha Bouaziz; Wissem Mnif; Aghleb Bartegi; Nidhal Ben Amor
Journal:  Med Oncol       Date:  2010-04-07       Impact factor: 3.064

2.  Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids.

Authors:  Michael C Peters; Sheena Kerr; Eleanor M Dunican; Prescott G Woodruff; Merritt L Fajt; Bruce D Levy; Elliot Israel; Brenda R Phillips; David T Mauger; Suzy A Comhair; Serpil C Erzurum; Mats W Johansson; Nizar N Jarjour; Andrea M Coverstone; Mario Castro; Annette T Hastie; Eugene R Bleecker; Sally E Wenzel; John V Fahy
Journal:  J Allergy Clin Immunol       Date:  2018-03-07       Impact factor: 10.793

3.  National asthma observational survey of severe asthmatics in Israel: the no-air study.

Authors:  Gabriel Izbicki; Anna Grosman; Zeev Weiler; Tiberiu Shulimzon; Uri Laxer; Gershon Fink
Journal:  Allergy Asthma Clin Immunol       Date:  2012-06-01       Impact factor: 3.406

4.  Perceptual accuracy of upper airway compromise in children: Clinical relevance and future directions for research.

Authors:  Daphne Koinis-Mitchell; Cynthia Esteban; Sheryl J Kopel; Barbara Jandasek; Katie Dansereau; Gregory K Fritz; Robert B Klein
Journal:  Allergy Rhinol (Providence)       Date:  2013

5.  Asthma treatment outcome in adults is associated with rs9910408 in TBX21 gene.

Authors:  Anton Lopert; Matija Rijavec; Mateja Zavbi; Peter Korošec; Matjaž Fležar
Journal:  Sci Rep       Date:  2013-10-10       Impact factor: 4.379

6.  The real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: The ASTERIX Observational study.

Authors:  Mohit Bhutani; William H Yang; Jacques Hébert; Frederica de Takacsy; Jean-Louis Stril
Journal:  PLoS One       Date:  2017-08-31       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.